ASCO: Oxaliplatin does not improve outcomes for rectal cancer
ASCO: Oxaliplatin does not improve outcomes for rectal cancer
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer
AACR 2009: Common genetic variations and predisposition to cancer
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours
AACR 2009: 100 years of AACR
AACR 2009: Determinants of screening colonoscopy among african-american older adults
AACR 2009: Genetic influences in response to EGFR for metastatic colorectal cancer
AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer
Bacteria as agents to initiate potent anti-tumour activity
ECCO 15 - ESMO 34 Executive Scientific Programme Committee
University Hospital Gasthuisberg
Flinders University, Australia